NVS

Novartis AG $137.16 1M -10.0% 3M -10.9% YTD -1.0% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.1%
Next 1 week
+0.3%
Next 1 month
-0.5%
Seasonality
No real seasonal tilt
Next 30 days (to Oct 14): -0.1% median, 48% of the last 29 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.01%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.34 -0.1% · Seasonal tilt -0.4%
$277.7B market cap (#40 US) $351M/day volume 27% volatility +8% 1-year -20% from ATH
52-week range · 32% of the way up · -20% from the high
$121.57$170.46

Congressional trades in NVS Full tracker →

22 members · 55 buys / 43 sells · $771K–$2.9M disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 31, 2026 $1K–$15K
BUY AA Alan Armstrong · traded Mar 30, 2026 $15K–$50K
SELL LM Lisa McClain · traded Oct 31, 2025 $1K–$15K
SELL LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
BUY LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
SELL LM Lisa McClain · traded Sep 25, 2025 $1K–$15K
BUY LM Lisa McClain · traded Sep 11, 2025 $1K–$15K
BUY LM Lisa McClain · traded Jun 11, 2025 $1K–$15K

Earnings Full history →

Next report 2026-10-27 (Tuesday, before open, in 43 days) · EPS est. 2.23.

1-day std dev
2.7%
Finished up
47%
Biggest pop
+4.8%
Biggest drop
-5.4%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.